SCHEMBL26136337

SCHEMBL26136337

CCNC(=O)Oc1ccc(Br)cc1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 5/20 0.67
KMT2A Q03164 2/20 0.52
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP14 P50281 1/20 0.47
ACHE P22303 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
BLM P54132 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28052018 0.86 MGLL (0.77) MGLLMMP2MMP9MMP14ACHE
SCHEMBL10812056 0.85 KMT2A (0.63) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL13911210 0.83 GAA (0.59) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL13944297 0.83 KMT2A (0.54) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL1690926 0.83 KMT2A (0.54) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL2453184 0.83 KMT2A (0.54) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL25226904 0.81 RAB9A (0.61) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL11341571 0.81 MGLL (0.58) MGLLKMT2ASMN1; SMN2MEN1GAA
SCHEMBL13724309 0.81 KMT2A (0.52) MGLLKMT2AMMP2MMP9MMP8
SCHEMBL16918662 0.81 FAAH (0.60) MGLLKMT2AMMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023185864-A1 Compounds for Targeted Degradation of KRAS JINGRUI BIOPHARMA CO., LTD. (CN) 2023-10-05 WO disclosed
CN-108136044-B Imide-based proteolytic modulators and related methods of use 阿尔维纳斯运营股份有限公司 2021-08-10 CN disclosed
CN-108136044-A Imide-based proteolytic modulators and related methods of use 阿尔维纳斯股份有限公司 2018-06-08 CN disclosed
CN-102917590-B Tricyclic compound and the PBK inhibitor containing described compound ONCOTHERAPY SCIENCE, INC. (JP) 2016-02-17 CN disclosed